We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Banner Life Sciences announced the U.S. Food and Drug Administration (FDA) granted tentative approval on November 16, 2018 of the company’s New Drug Application (NDA 505(b)(2)) for BAFIERTAM......